Bendazac is a non-steroidal anti-inflammatory drug (NSAID).1,2 It prevents denaturation of lens and serum proteins in vitro.1 Bendazac (10-40 mM) prevents cyanate-induced opacification of the eye lens in a rat model of cataract.3
1.Harding, J.J.Pharmacological treatment strategies in age-related cataractsDrugs Aging2(4)287-300(1992) 2.Guglielmotti, A., Capezzone De Joannon, A., Cazzolla, N., et al.Radical scavenger activity of bendazac, an anticataract non-steroidal anti-inflammatory agentPharmacol. Res.32(6)369-373(1995) 3.Lewis, B.S., and Harding, J.J.Evaluation of bendazac, a putative anti-cataract drug, in preventing the effects of cyanate in models of cataractT. Aging Res.6127-130(1986)